---
figid: PMC6770737__cells-08-00948-g008
figtitle: Schematic representation of the antiproliferative and antimetastatic effects
  of fisetin in human RCC cells
organisms:
- Homo sapiens
- Mus musculus
- herbal medicine
pmcid: PMC6770737
filename: cells-08-00948-g008.jpg
figlink: /pmc/articles/PMC6770737/figure/cells-08-00948-f008/
number: F8
caption: Schematic representation of the antiproliferative and antimetastatic effects
  of fisetin in human RCC cells. Fisetin has antiproliferative and antimetastatic
  effects on human RCC cells mediated by the downregulation of CTSS and ADAM9 through
  the ERK signaling pathway.
papertitle: Fisetin Suppresses the Proliferation and Metastasis of Renal Cell Carcinoma
  through Upregulation of MEK/ERK-Targeting CTSS and ADAM9.
reftext: Min-Hong Hsieh, et al. Cells. 2019 Sep;8(9):948.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9311331
figid_alias: PMC6770737__F8
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC6770737__F8
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6770737__cells-08-00948-g008.html
  '@type': Dataset
  description: Schematic representation of the antiproliferative and antimetastatic
    effects of fisetin in human RCC cells. Fisetin has antiproliferative and antimetastatic
    effects on human RCC cells mediated by the downregulation of CTSS and ADAM9 through
    the ERK signaling pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - oh
  - Ephb2
  - Mapk1
  - Ctss
  - Adam9
  - Gabrg2
  - EPHB2
  - MAPK1
  - MAPK3
  - XRCC1
  - PBRM1
  - CTSS
  - ADAM9
  - WARS1
  - Fisetin
---
